跳至主要内容
临床试验/IRCT20170311033004N4
IRCT20170311033004N4招募中2 期

Evaluation of efficacy and safety of Psilocybe cubensis on depression and PTSD symptoms of veterans; a randomized, double-blind, placebo-controlled trial

Iranian academic center for education culture and research0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
Male

入选标准

  • patients with PTSD diagnosis
  • moderate to severe depression
  • male aged 45-75 years without any previous diagnosis of other mental disorders such as
  • without any previous diagnosis of diabetes or CV disorders
  • without diagnosis of the other mental disorders
  • taking antidepressants SSRIs or SNRIs
  • not hospitalized

排除标准

  • they have a diagnosis of psychosis
  • suicide attempting
  • taking antidepressants except for SSRIs and SNRIs or electroconvulsive therapy
  • follow up interrupting
  • sensitivity to the mushroom
  • emerging adverse effects including fever, GI and heart diseases
  • hospitalization

研究者

发起方
Iranian academic center for education culture and research

相似试验

Evaluation of efficacy and safety of Psilocybe... | 临床试验